Retrotope
Los Altos Hills
About Retrotope
Retrotope creates a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. It is a privately held company focused on the development of ways of controlling metabolic processes associated with oxidative stress conditions. Retrotope uses isotope effect to slow down damaging pathways. The company has several discovery and development programs that involve major classes of biopolymers, with the major focus on neurological diseases such as Friedreich's ataxia. It was founded in 2006 and is located in Los Altos Hills, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $82.7M
- Funding stage: Late Stage Venture
- Last round: Series D (Sep 2020)
- Website: retrotope.com
- Phone: (650) 917-9256
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/retrotope-7759 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.